Drug profile · INN
diflunisal
ATTROGY
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
diflunisal (ATTROGY) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN diflunisal
Brand ATTROGY
Route ORAL
Formulation TABLET
ATC code N02BA11
Originator Teva Pharma GmbH
Frequently asked questions
What is diflunisal?
diflunisal (ATTROGY) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for diflunisal?
ATTROGY is a marketed brand name for diflunisal. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diflunisal?
diflunisal has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.